This page is not available in the language that has been selected and will appear in English.
This guide helps you understand your diagnosis, explore care options, and support yourself and others during treatment.
We cover essential terminology including treatment terms, medical procedures, common side effects, and more.
Your options for treatment may be varied or few, so our guide aims to offer an extensive run-down of options.
This guide gives you a full list of questions and tips to get the most out of every appointment with your doctor.
Your guide to managing cancer treatment, from preparing for side effects to the impacts on fertility and beyond.
Find a clinical trial that may suit you and your cancer diagnosis
X4P-001-110
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Locations Southport
Diagnosis Neutropenic disorders
NIAGARA-2 / D933RC00002
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer
Locations Chermside
Diagnosis Bladder cancer
OLYMPIA-3 / R1979-ONC-2105
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Locations Wesley
Diagnosis Lymphoma - B-cell Non Hodgkin's
SKB264-II-06
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Diagnosis Advanced solid tumours
SGNDV-001
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Diagnosis Urotherlial cancer
OM336-AIC-1001
An open-label, multicenter, ascending dose study, evaluating safety, tolerability, and PK/ADA of OM336 in autoimmune cytopenias.
Locations Wesley, South Brisbane
Diagnosis Immune Thrombocytopenia (ITP)